Author:
Sebastian M.,Stratmann J.
Publisher
Springer Science and Business Media LLC
Reference90 articles.
1. Lowenbraun S, Bartolucci A, Smalley RV, Lynn M, Krauss S, Durant JR (1979) The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer 44(2):406–413
2. Green RA, Humphrey E, Close H, Patno ME (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 46(4):516–525
3. Souhami RL, Law K (1990) Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br J Cancer 61(4):584–589
4. Amarasena IU, Chatterjee S, Walters JAE, Wood-Baker R, Fong KM (2015) Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev. doi: 10.1002/14651858.cd006849.pub3
5. Lee SM, James LE, Qian W, Spiro S, Eisen T, Gower NH et al (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax 64(1):75–80